LONGBIO-B (01779) announced its inclusion in the eligible securities lists under both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, taking effect from September 7, 2026.
According to the company's statement, the Shanghai Stock Exchange released the "Notice on Adjustments to Eligible Targets under the Shanghai-Hong Kong Stock Connect" on September 4, 2026, followed by the Shenzhen Stock Exchange's "Announcement on Adjustments to the Eligible Securities List under the Shenzhen-Hong Kong Stock Connect" on September 7, 2026.
Following this designation, eligible mainland Chinese investors will be able to trade the company's shares directly through both the Shanghai and Shenzhen stock exchanges. The board believes this inclusion reflects strong market recognition of the company's investment value and growth prospects.
The company anticipates that being added to these trading mechanisms will broaden its shareholder base, attract more long-term institutional investors, enhance share trading liquidity, and build a solid foundation for long-term development, ultimately boosting its investment appeal and reputation in the capital markets.